APAC Negative Pressure Wound Therapy Market

APAC Negative Pressure Wound Therapy Market Size (2023 to 2028)

The negative pressure wound therapy market in Asia-Pacific is predicted to grow at a CAGR of 8.02% between 2023 to 2028. As a result, the market size is expected to be USD 572.5 million in 2023 and USD 841.9 million by 2028.

Chronic wounds suffered by patients due to being involved in accidents and unfortunate events are driving the NPWT market in the Asia-Pacific region. Chronic wounds are a type of ailment or physical damage which take more time to heal than usual; therefore, in recent times, the rise of diabetic cases is pushing the revenue for the market. Nearly 5% of diabetes patients suffer from foot ulcer problems, and diabetic wounds such as diabetic foot ulcers play a significant role in taking negative pressure wound therapy. The fluctuations of the glucose levels in the blood cause the wounds not to heal fast, leading to prolonged damage for patients.  In these patients, the wounds may escalate to a worse state significantly faster than average. In recent years negative pressure wound therapy has been one of the most used therapies in this region to get a fast cure for the wound because, when compared to the other treatments for this wound, negative pressure therapy reduces the inflammation around the wound and reduces the wound size at a fast pace.

The increasing advancements in negative pressure wound therapy, like Manufacturing different types of portable devices for the therapy and increasing the quality of the therapy to support the patient's wellness, along with the increasing use of single-use and disposable harmful pressure wound therapy devices in many regions are driving the revenue for the market. Furthermore, the advent of portable devices in the negative pressure wound therapy devices industry supports the rise of the market due to the increased spread of the pandemic and the shift toward online and at-home remote healthcare. Patients with covid are more prone to contracting chronic wounds, especially if they are patients with diabetes. Therefore, further treatments at home were preferred to avoid spreading the disease. Additionally, manufacturers are focusing on producing single-use harmful pressure wound devices to reduce the infection spread among patients.

Lack of awareness and increasing side effects like infection, blood, and several other complications due to improper treatment by caregivers and self-administered home-based treatment are restraining the market growth. In addition, the growing cost of advanced NPWT devices and strict regulatory policies also hamper the market growth.

This market research report on the APAC negative pressure wound therapy market has been segmented and sub-segmented into the following categories.

By Product Type:

• Conventional NPWT Devices
• Single-use NPWT Devices
• Accessories

By Wound Type:

• Surgical and Traumatic Wounds
• Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Diabetic Foot Ulcers
  • Other Ulcers
• Burns

By End-User:

• Hospitals
• Home Care Settings
• Other End Users

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Asia Pacific had a substantial share of the global market in 2022 and is anticipated to grow the fastest during the forecast period owing to the factors such as existing techniques for faster wound healing, increasing home health care, improving wound healing, less skin damage, and less need for hospital treatments, driving the market forward in this region.

The Indian market in this region is anticipated to play a promising role during the forecast period. An increasing number of surgical procedures in India, along with the increasing healthcare spending on chronic and surgical wounds, is the primary factor driving the market in India. Increasing surgical procedures also increase chronic wounds, requiring negative pressure wound therapy, the latest advanced therapy to treat chronic wounds. In India, this therapy is mainly used for patients who are suffering from skin burn diseases. Negative pressure therapy is used in post-surgical stages to manage the wound areas by increasing the growth of the healthy granulation tissues in patients and decreasing the pain in burn patients.

The Chinese market is expected to grow at a healthy CAGR during the forecast period. China is supporting more research on the chronic pressure wound therapy market for curing different wounds. In 2022, Chinese regulators approved a negative pressure wound treatment device named CG Bios. This device helps prevent contamination, increase blood flow, and relieve pain quickly.

The Japanese market is also expected to grow steadily during the forecast period. Japan launched different types of devices for chronic wound therapy. Increasing product approvals by the government and minimal treatment costs are driving the market forward.

KEY MARKET PARTICIPANTS:

Acelity, Smith & Nephew, Mölnlycke Health Care AB, Convatec Group, Cardinal Health, Paul Hartmann AG, Deroyal, Lohmann & Rauscher International, Cork Medical, Chongqing Sunshine Medical Industry and Trading, Wuhan VSD Medical Science & Technology are some of the notable players operating in the Asia-Pacific negative pressure wound therapy market.